[Translated article] RF-Longer Dupilumab Dosing Intervals in Atopic Dermatitis: Optimization or Therapeutic Failure?

M A Lasheras-Pérez; F Navarro-Blanco; M Rodríguez-Serna

doi:10.1016/j.ad.2024.07.008

[Translated article] RF-Longer Dupilumab Dosing Intervals in Atopic Dermatitis: Optimization or Therapeutic Failure?

Actas Dermosifiliogr. 2024 Sep;115(8):T825-T827. doi: 10.1016/j.ad.2024.07.008. Epub 2024 Jul 5.

[Article in English, Spanish]

Authors

M A Lasheras-Pérez¹, F Navarro-Blanco², M Rodríguez-Serna²

Affiliations

¹ Servicio de Dermatología y Venereología, Hospital Universitario y Politécnico la Fe, Valencia, Spain. Electronic address: [email protected].
² Servicio de Dermatología y Venereología, Hospital Universitario y Politécnico la Fe, Valencia, Spain.

PMID: 38972581
DOI: 10.1016/j.ad.2024.07.008

No abstract available

Keywords: Adult; Adulto; Atopic dermatitis; Dermatitis atópica; Dose reduction; Dupilumab; Efficiency; Eficiencia; Optimización terapéutica; Reducción dosis; Therapeutic optimization.

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / administration & dosage
Antibodies, Monoclonal, Humanized* / therapeutic use
Dermatitis, Atopic* / drug therapy
Drug Administration Schedule*
Humans
Treatment Failure

Substances

dupilumab
Antibodies, Monoclonal, Humanized